Stanford Medicine researchers take a unique approach to refine engineered immune cells meant to kill cancer.
Stanford Medicine Scientists have devised a blood test to predict some cancer relapses after patients have already been treated.
'Resting' exhausted cancer-fighting immune cells enhances their tumor-killing activity, which may help people with blood and solid cancers.
In this In the Spotlight, hematologist/oncologist Gabriel Mannis talks about his passion for medicine and his experience working at Sesame Street.
Stanford scientists have moved a big step closer toward using engineered immune cells to treat many forms of pediatric cancer.
After a year of baffling symptoms, two Stanford specialists pieced together the puzzle of this woman's disease.
Monitoring changes in the levels of circulating bits of tumor DNA may help some lymphoma patients avoid unnecessary chemotherapy, Stanford researchers find.
A new technique gives doctors an early view of which pediatric leukemia patients will relapse, and may point the way toward better cancer drugs.
As a parent, some stories are more difficult to write than others. My recent Stanford Medicine magazine article about kids with leukemia is an example. …
Last August, a new leukemia therapy called CAR T-cells burst onto the national stage when it was approved by the Food and Drug Administration to …
More than 20 years ago, for a high school science project, I gave a presentation to my biology class on gene therapy. To me, the …
Confronted in 2002 by a medical record that was literally two feet in height, Stanford hematologist Jason Gotlib, MD, had no idea that his career path …
The question sounds more like sociology than biology: What would happen if you could take a cell gone bad -- a cancer cell -- bring …
When computer scientist Andrew A. Radin came to Stanford University School of Medicine and enrolled in a biomedical informatics course, he was just there to …
In the history of science and medicine, the breakthrough discoveries get a lot of deserved attention, but often overlooked are the invention of the tools …
What would you do if your toddler had a very rare blood cancer and his treatments were failing? At what point would you decide that …
